Patents-Review.com
ClassID:

20912 ⎘

A61K38/164 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Recent Application in this class:
#301
20210017239
2021-01-21

PROTEINS WITH DIAGNOSTIC AND THERAPEUTIC USES

 #302
20210017236
2021-01-21

Antibacterial method

 #303
20210009664
2021-01-14

Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets

 #304
20210009648
2021-01-14

PEPTIDES FOR TREATMENT OF DIABETES

 #305
20210008157
2021-01-14

Nano-vesicles derived from genus cupriavidus bacteria and use thereof

 #306
20210008156
2021-01-14

NOVEL RECOMBINANT BOTULINUM NEUROTOXINS WITH INCREASED DURATION OF EFFECT

 #307
20210002351
2021-01-07

Polymeric forms of H-NOX proteins

 #308
20210000964
2021-01-07

Fatty acids and their use in conjugation to biomolecules

 #309
20210000884
2021-01-07

Proteins derived from bacteria and use thereof

 #310
20200405871
2020-12-31

Immunogenic compositions

 #311
20200405857
2020-12-31

Radiation-triggered liposomes

 #312
20200405835
2020-12-31

FhuD2 fusion proteins for the outer membrane vesicle (OMV) delivery of heterologous polypetides and immunogenic compositions thereof

 #313
20200405806
2020-12-31

COMBINATION OF A TETANUS TOXOID, ANTI-OX40 ANTIBODY AND/OR ANTI-PD-1 ANTIBODY TO TREAT TUMORS

 #314
20200392211
2020-12-17

Methods of treating and preventing infections and associated conditions

 #315
20200392190
2020-12-17

Flagellin-based agents and uses including effective vaccination

 #316
20200390861
2020-12-17

IL-4-fusion formulations for treatment of central nervous system (CNS) tumors

 #317
20200390852
2020-12-17

Compositions and methods for treating peripheral nerve disease, disorders, and injuries

 #318
20200390851
2020-12-17

Viral treatment

 #319
20200386755
2020-12-10

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

 #320
20200376076
2020-12-03

Composition comprising an algal proteoglycan extract and use thereof

 #321
20200368315
2020-11-26

ANTIMICROBIAL PEPTIDES AND ADMIXTURES THEREOF SHOWING ANTIMICROBIAL ACTIVITY AGAINST GRAM-NEGATIVE PATHOGENS

 #322
20200361999
2020-11-19

Heme sequesting peptides and uses therefor

 #323
20200360677
2020-11-19

Systems and methods for delivery of a therapeutic agent

 #324
20200360511
2020-11-19

Aluminum compounds for use in therapeutics and vaccines

 #325
20200360470
2020-11-19

Composition comprising an algal proteoglycan extract and use thereof

 #326
20200352851
2020-11-12

METHOD OF TREATING AN EYE DISORDER BY INHIBITING OR DISRUPTING BACTERIAL BIOFILM FORMATION

 #327
20200338159
2020-10-29

Composition comprising an algal proteoglycan extract and use thereof

 #328
20200306342
2020-10-01

Nutritive polypeptides and formulations thereof, and methods of production and use thereof

 #329
20200306339
2020-10-01

Treatment and diagnosis of inflammatory disorders and HIV

 #330
20200297783
2020-09-24

Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof

 #331
20200277348
2020-09-03

Multi specific molecules

 #332
20200277339
2020-09-03

Flagellin compositions and uses

 #333
20200276265
2020-09-03

MODULATION HYPOXIA ASSOCIATED WITH STROKE

 #334
20200276263
2020-09-03

Treatments of oxidative stress conditions

 #335
20200268836
2020-08-27

Albumin-proaerolysin prodrugs

 #336
20200261535
2020-08-20

Flagellin related polypeptides and uses thereof

 #337
20200254035
2020-08-13

PHAGE AND TRANSDUCTION PARTICLES

 #338
20200246397
2020-08-06

Antimicrobial therapy

 #339
20200238064
2020-07-30

Systems and methods for delivery of a therapeutic agent

 #340
20200237858
2020-07-30

DAPTOMYCIN FORMULATIONS AND USES THEREOF

 #341
20200230223
2020-07-23

Immunogenic proteins against

#342
20200222511
2020-07-16

TREATMENT OF MERKEL CELL POLYOMAVIRUS INFECTION

 #343
20200215151
2020-07-09

THERAPEUTIC COMPOSITION FOR INFLAMMATION/TISSUE INJURY

 #344
20200207814
2020-07-02

surface layer protein a (SlpA) as a therapeutic agent for the treatment of inflammatory diseases

 #345
20200188481
2020-06-18

Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof

 #346
20200188452
2020-06-18

Purified anthelmintic compositions and related methods

 #347
20200188451
2020-06-18

()-derived factors for the treatment of treatment/prevention of excess oxalate levels

 #348
20200181206
2020-06-11

Proteins for the treatment of epithelial barrier function disorders

 #349
20200179618
2020-06-11

SYSTEMS AND METHODS FOR BOTULINUM TOXIN OR OTHER DRUG INJECTIONS FOR MEDICAL TREATMENT

 #350
20200172582
2020-06-04

surface layer protein A (SLPA) as a therapeutic agent for the treatment of inflammatory diseases

 #351
20200164090
2020-05-28

Polymeric nanoparticles for enhanced cancer immunotherapy

 #352
20200164027
2020-05-28

Pirin polypeptide and immune modulation

 #353
20200155653
2020-05-21

Use of pertussis toxin as a therapeutic agent

 #354
20200155643
2020-05-21

Engineered anthrax protective antigen proteins for cancer therapy

 #355
20200155642
2020-05-21

PURIFICATION OF ALGAL EXTRACTS AND THEIR APPLICATIONS

 #356
20200148776
2020-05-14

Compositions and methods for non-myeloablative conditioning

 #357
20200139151
2020-05-07

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #358
20200138906
2020-05-07

METHOD OF TREATING A BLADDER CANCER USING A CHIMERIC EGF-TARGETED BACTERIAL TOXIN

 #359
20200138899
2020-05-07

Topical compositions comprising OB-fold variants

 #360
20200129629
2020-04-30

Glycotargeting therapeutics

 #361
20200129587
2020-04-30

Recombinant clostridial neurotoxins with increased duration of effect

 #362
20200123209
2020-04-23

Antimicrobial type-II bacteriocins

 #363
20200121756
2020-04-23

COMPOSITIONS COMPRISING BACTERIAL STRAINS

 #364
20200114162
2020-04-16

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #365
20200113818
2020-04-16

Dental strips for the delivery of specifically targeted antimicrobial peptides

 #366
20200101160
2020-04-02

Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy

 #367
20200095297
2020-03-26

Peptides for treatment of diabetes

 #368
20200093910
2020-03-26

Subunit vaccine delivery platform for robust humoral and cellular immune responses

 #369
20200093888
2020-03-26

Labyrinthopeptins as anti-viral agents

 #370
20200078457
2020-03-12

Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy

 #371
20200071703
2020-03-05

Viral vectors for treating neurogenic detrusor overactivity

 #372
20200069794
2020-03-05

Respiratory virus nucleic acid vaccines

 #373
20200061152
2020-02-27

Proteins for the treatment of epithelial barrier function disorders

 #374
20200054441
2020-02-20

Method for stimulating retinal cells and treating vision loss

 #375
20200046955
2020-02-13

Systems and methods for delivery of a therapeutic agent

 #376
20200038493
2020-02-06

Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy

 #377
20200031879
2020-01-30

COMPOSITION COMPRISING RECOMBINANT FUSION PROTEIN OF PATHOGENIC ANTIGEN PROTEIN AND FLAGELLIN OF VIBRIO VULNIFICUS FOR PREVENTING, ALLEVIATING, OR TREATING AGING

 #378
20200030417
2020-01-30

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

 #379
20200023049
2020-01-23

Proteins and nucleic acids useful in vaccines targeting

#380
20200022942
2020-01-23

Homogenous antibody drug conjugates via enzymatic methods

 #381
20200017574
2020-01-16

Polymeric forms of H-NOX proteins

 #382
20200016243
2020-01-16

TREATMENT OF INFECTION BY HUMAN ENTEROVIRUS D68

 #383
20200009397
2020-01-09

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #384
20200009239
2020-01-09

Compositions, methods and therapies for administering antigen peptide

 #385
20200000876
2020-01-02

Bioengineered lactobacillus probiotics and the uses thereof

 #386
20200000875
2020-01-02

Injectable self-assembling antibacterial peptide hydrogels

 #387
20190388700
2019-12-26

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #388
20190388521
2019-12-26

REDUCTION OF EGFR THERAPEUTIC TOXICITY

 #389
20190387745
2019-12-26

Biofilm prevention, disruption and treatment with bacteriophage lysin

 #390
20190383812
2019-12-19

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

 #391
20190381139
2019-12-19

Protection against stress-mediated damage from ionizing radiation

 #392
20190358304
2019-11-28

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertensions, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders

 #393
20190358291
2019-11-28

Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy

 #394
20190351034
2019-11-21

Non-protein clostridial toxin compositions

 #395
20190351014
2019-11-21

COMPOSITIONS OF TOLL-LIKE RECEPTOR 5 (TLR5) AGONIST AND METHODS OF USE THEREOF

 #396
20190338010
2019-11-07

Fusion proteins of collagen-binding domain and parathyroid hormone

 #397
20190336571
2019-11-07

NEUROTOXIN FOR USE IN THE TREATMENT OF PERSONALITY DISORDERS

 #398
20190328859
2019-10-31

CLOSTRIDIUM DIFFICILE ANTIGENS

 #399
20190328835
2019-10-31

Means and methods for treating copper-related diseases

 #400
20190328801
2019-10-31

Microorganism for delivering drug for treatment of gastrointestinal disease, which expresses and secretes P8 protein, and pharmaceutical composition for preventing or treating gastrointestinal disease, which includes the same

 #401
20190323860
2019-10-24

Compositions for the inhibition of

#402
20190321453
2019-10-24

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

 #403
20190315814
2019-10-17

LANTIBIOTIC VARIANTS AND USES THEREOF

 #404
20190315810
2019-10-17

Flagellin-based agents and uses including effective vaccination

 #405
20190307839
2019-10-10

Enzyme Replacement Therapy for Melanoma

 #406
20190300583
2019-10-03

NEUROTOXINS FOR USE IN INHIBITING CGRP

 #407
20190290724
2019-09-26

COMPOSITIONS AND USES THEREOF

 #408
20190275128
2019-09-12

Use of toll-like receptor agonist for treating cancer

 #409
20190273531
2019-09-05

FHSS hotspot device and methods

 #410
20190269773
2019-09-05

Methods and compositions for adaptive immune modulation

 #411
20190248876
2019-08-15

CELLULAR FACTORS INVOLVED IN THE CYTOTOXICITY OF STAPHYLOCOCCUS AUREUS LEUKOCIDINS: NOVEL THERAPEUTIC TARGETS

 #412
20190247460
2019-08-15

Cell modulation

 #413
20190247227
2019-08-15

Methods for treatment of dry eye and other acute or chronic inflammatory processes

 #414
20190240500
2019-08-08

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #415
20190240287
2019-08-08

INHIBITOR OF RNA POLYMERASE II

 #416
20190240286
2019-08-08

Compositions and methods for treating disease using T3SS effector protein (SipA)

 #417
20190233478
2019-08-01

Flagellin compositions and uses

 #418
20190231853
2019-08-01

Treatment and/or prevention of sepsis

 #419
20190231846
2019-08-01

LIGHT-SENSITIVE PUMPS FOR SUPPRESSION OF CARDIAC ACTIVITY

 #420
20190231828
2019-08-01

Methods of microbial treatment of poultry

 #421
20190224492
2019-07-25

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #422
20190216892
2019-07-18

Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted antigen intensity, increasing antitumor efficacy

 #423
20190216889
2019-07-18

METHODS AND COMPOSITIONS FOR TREATMENT OF FIBROSIS

 #424
20190211066
2019-07-11

VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS

 #425
20190209646
2019-07-11

Bacterial inhibitors

 #426
20190201481
2019-07-04

Protein P8 derived from lactic acid bacteria and its use as anti-cancer agent

 #427
20190201480
2019-07-04

COMBINED VACCINATION/RADIOTERAPY FOR CANCER TREATMENT

 #428
20190192676
2019-06-27

Immunostimulant

 #429
20190192621
2019-06-27

Treatment and diagnosis of inflammatory disorders and HIV

 #430
20190184015
2019-06-20

IRRADIATION TREATMENT OF NEUROLOGICAL SENSATIONS BY PHOTOABLATION

 #431
20190169251
2019-06-06

Methods for inhibiting hematopoietic tumor cells with diphtheria tokin-interleukin-3 conjugates

 #432
20190167760
2019-06-06

Polypeptides binding to human complement C5

 #433
20190160300
2019-05-30

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #434
20190160143
2019-05-30

ANTIBACTERIAL COMPOSITION COMPRISING MICROCIN S AND ANTIBIOTIC

 #435
20190160120
2019-05-30

DNA, METHODS ETC

 #436
20190151408
2019-05-23

COLICINS FOR TREATING BACTERIAL INFECTIONS

 #437
20190151407
2019-05-23

Flagellin related polypeptides and uses thereof

 #438
20190142956
2019-05-16

Compositions and methods for the inhibition of fibrosis

 #439
20190142896
2019-05-16

Methods and compositions for the treatment of radiation-related disorders

 #440
20190142880
2019-05-16

THE USE OF PHYCOCYANINS, PURIFIED OR AS PRESENT IN CYANOBACTERIAL MICROALGAE OR EXTRACTS THEREOF, AS PREBIOTICS, TO ENHANCE THE VIABILITY, GASTROINTESTINAL SURVIVAL, PATHOGEN-FIGHTING ABILITY, AND THE OVERALL HEALTH-ENHANCING PROPERTIES OF PROBIOTIC CULTURES AND PRODUCTS.

 #441
20190142876
2019-05-16

based pharmaceutical and food compositions for inducing satiation and prolonging satiety

 #442
20190135902
2019-05-09

Immunotherapies employing self-assembling vaccines

 #443
20190135900
2019-05-09

Methods of treating and preventing infections and associated conditions

 #444
20190135890
2019-05-09

Fusion proteins of collagen-binding domain and parathyroid hormone

 #445
20190134179
2019-05-09

COMPOSITIONS CONTAINING COMBINATIONS OF BIOACTIVE MOLECULES DERIVED FROM MICROBIOTA FOR TREATMENT OF DISEASE

 #446
20190133947
2019-05-09

Pharmaceutical Peptides and Rhamnolipid Liposomes

 #447
20190117993
2019-04-25

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #448
20190117744
2019-04-25

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

 #449
20190117743
2019-04-25

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

 #450
20190117742
2019-04-25

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

 #451
20190117727
2019-04-25

Compositions and methods for topical delivery of pharmaceutical agents

 #452
20190111106
2019-04-18

Compositions for inhibiting formation of and/or disrupting bacterial biofilms and methods of use therefor

 #453
20190106479
2019-04-11

Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use

 #454
20190105507
2019-04-11

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #455
20190105401
2019-04-11

Peptide-mediated drug delivery across epithelial barrier

 #456
20190105375
2019-04-11

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

 #457
20190100593
2019-04-04

Compositions and methods for non-myeloablative conditioning

 #458
20190100563
2019-04-04

Proteins with diagnostic and therapeutic uses

 #459
20190099611
2019-04-04

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #460
20190099469
2019-04-04

Method for the treatment of acne

 #461
20190099442
2019-04-04

Artificial invaplex formulated with deacylated lipopolysaccharide

 #462
20190091142
2019-03-28

Method of treating an eye disorder by inhibiting or disrupting bacterial biofilm formation

 #463
20190085035
2019-03-21

Secretagogues derived from oxalobacter formigenes

 #464
20190083768
2019-03-21

Systems and methods for delivery of a therapeutic agent

 #465
20190083592
2019-03-21

IMMUNOSTIMULATORY COMBINATIONS

 #466
20190083455
2019-03-21

METHODS AND COMPOSITIONS FOR THE MODULATION OF BETA-ENDORPHIN LEVELS

 #467
20190077838
2019-03-14

Method for inhibiting, improving, or preventing aging using recombinant fusion protein of pathogenic antigen protein and flagellin of

#468
20190071648
2019-03-07

Modified bacteriophage

 #469
20190071472
2019-03-07

Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses

 #470
20190048077
2019-02-14

Methods and compositions for the prevention and treatment of surgical adhesions

 #471
20190046629
2019-02-14

METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE

 #472
20190046605
2019-02-14

Compositions comprising cupredoxins for treating cancer

 #473
20190046604
2019-02-14

LABYRINTHOPEPTINS AS ANTI-VIRAL AGENTS

 #474
20190038908
2019-02-07

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #475
20190030118
2019-01-31

TREATMENT OF LOWER LIMB SPASTICITY

 #476
20190023789
2019-01-24

Immunomodulation by anti-CD3 immunotoxins to treat cancers bearing or not uniformly bearing surface CD3

 #477
20190022195
2019-01-24

FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION

 #478
20190022177
2019-01-24

Composition comprising an algal proteoglycan extract and use thereof

 #479
20190016762
2019-01-17

surface layer protein A (SlpA) as a therapeutic agent for the treatment of inflammatory diseases

 #480
20190015677
2019-01-17

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #481
20190015496
2019-01-17

Proteins and nucleic acids useful in vaccines targeting

#482
20190015484
2019-01-17

NICOTINE-DEGRADING ENZYMES FOR TREATING NICOTINE ADDICTION AND NICOTINE POISONING

 #483
20190015474
2019-01-17

Anthelmintic compositions and methods

 #484
20190000865
2019-01-03

MATERIALS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS AND FOR INDUCTION OF ION SECRETION

 #485
20180361169
2018-12-20

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #486
20180360958
2018-12-20

Vaccines with interleukin-33 as an adjuvant

 #487
20180360794
2018-12-20

Homogenous antibody drug conjugates via enzymatic methods

 #488
20180360793
2018-12-20

Homogenous antibody drug conjugates via enzymatic methods

 #489
20180354995
2018-12-13

FLAGELLIN-BASED AGENTS AND USES INCLUDING EFFECTIVE VACCINATION

 #490
20180346526
2018-12-06

Peptides having antimicrobial activity and new enzyme capable of converting L-configured residue in D-configured amino acid in a peptide

 #491
20180346524
2018-12-06

Bacteriocin composition and method

 #492
20180345033
2018-12-06

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #493
20180344834
2018-12-06

Immunogenic proteins against clostridium difficile

 #494
20180344823
2018-12-06

Use of toll-like receptor agonist for treating cancer

 #495
20180344807
2018-12-06

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 #496
20180344806
2018-12-06

Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals

 #497
20180344642
2018-12-06

Echinomycin formulation, method of making and method of use thereof

 #498
20180333442
2018-11-22

PROBIOTIC COMPOSITIONS AND METHODS OF USE THEREOF

 #499
20180327780
2018-11-15

CYP-P22 biocatalytic nanoparticles with cytochrome P450 activity for prodrug activation

 #500
20180326079
2018-11-15

Fatty acids and their use in conjugation to biomolecules

 #501
20180319848
2018-11-08

Modifications of cupredoxin derived peptides

 #502
20180319847
2018-11-08

Compositions and methods for treating conditions related to ephrin signaling with Cupredoxins

 #503
20180318396
2018-11-08

Methods of treating or preventing pruritis by blocking natriuretic polypeptide b

 #504
20180311346
2018-11-01

Combination therapy of immunotoxin and checkpoint inhibitor

 #505
20180311310
2018-11-01

Therapeutic and diagnostics compositions targeting toll-like receptors and methods thereof

 #506
20180303951
2018-10-25

Glycotargeting therapeutics

 #507
20180296635
2018-10-18

Protein particles comprising disulfide crosslinkers and uses related thereto

 #508
20180289751
2018-10-11

ANTIMICROBIAL THERAPY

 #509
20180280716
2018-10-04

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #510
20180274036
2018-09-27

Methods and compositions for detecting risk of cancer relapse

 #511
20180264078
2018-09-20

Microcin and uses thereof

 #512
20180264077
2018-09-20

Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza

 #513
20180251498
2018-09-06

Flagellin compositions and uses

 #514
20180250360
2018-09-06

METHOD FOR DETECTING CANCER CELLS, REAGENT FOR INTRODUCING SUBSTANCE INTO CANCER CELLS, AND COMPOSITION FOR TREATING CANCER

 #515
20180243365
2018-08-30

Peptide inhibitors of clostridium difficile toxin B (TcdB) toxin

 #516
20180243364
2018-08-30

MODULATION OF TUMOR IMMUNITY BY PROTEIN-MEDIATED 02 DELIVERY

 #517
20180236099
2018-08-23

SALIPRO PARTICLES

 #518
20180236040
2018-08-23

Use of a pharmaceutical composition containing at least one digestive enzyme in artificial feeding

 #519
20180236002
2018-08-23

Compositions and methods for treating graft versus host disease

 #520
20180224450
2018-08-09

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

 #521
20180221460
2018-08-09

Treatment of mammalian physiological reaction of IgE antibodies present in said mammal upon contact with the corresponding antigen

 #522
20180221436
2018-08-09

Treatments of oxidative stress conditions

 #523
20180214711
2018-08-02

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #524
20180214511
2018-08-02

Engineered anthrax protective antigen proteins for cancer therapy

 #525
20180208629
2018-07-26

Composition for preventing spp. infection

 #526
20180207079
2018-07-26

Compositions for protecting skin comprising DNA repair enzymes and phycobiliprotein

 #527
20180200330
2018-07-19

Compositions and Methods for the Treatment of Diseases Related to the Renin-Angiotensin-System

 #528
20180194819
2018-07-12

Binding proteins based on di-ubiquitin muteins and methods for generation

 #529
20180177843
2018-06-28

Daptomycin formulations and uses thereof

 #530
20180169182
2018-06-21

Recombinant clostridial neurotoxins with increased duration of effect

 #531
20180153959
2018-06-07

Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof

 #532
20180147290
2018-05-31

Antibacterial products

 #533
20180140862
2018-05-24

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #534
20180140666
2018-05-24

FLAGELLIN FUSION PROTEINS AND CONJUGATES COMPRISING PNEUMOCOCCUS ANTIGENS AND METHODS OF USING THE SAME

 #535
20180140665
2018-05-24

Immunomodulatory and oncolytic minicells and methods of use

 #536
20180140664
2018-05-24

Methods, reagents and kits for detecting minimal residual disease

 #537
20180140663
2018-05-24

Flagellin related polypeptides and uses thereof

 #538
20180133501
2018-05-17

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #539
20180133299
2018-05-17

Compositions, methods and therapies for administering antigen peptide

 #540
20180125925
2018-05-10

Therapeutical tools and methods for treating blindness

 #541
20180118792
2018-05-03

Composition comprising recombinant fusion protein of pathogenic antigen protein and flagellin of vibrio vulnificus for preventing, alleviating, or treating aging

 #542
20180110846
2018-04-26

IL-23-p19 vaccines

 #543
20180104355
2018-04-19

Dosing strategies for targeting EPCAM positive bladder cancer

 #544
20180104305
2018-04-19

Treatment and diagnosis of inflammatory disorders and HIV

 #545
20180087117
2018-03-29

ANTI-MICROBIAL AGENT FROM PAENIBACILLUS SP. AND METHODS AND USES THEREOF

 #546
20180085429
2018-03-29

Anti-inflammatory peptides and methods for treating inflammatory diseases

 #547
20180085428
2018-03-29

Polypeptides binding to human complement C5

 #548
20180085427
2018-03-29

Oral administration compositions comprising an OB-fold protein variant

 #549
20180072778
2018-03-15

Polypeptide and immune modulation

 #550
20180071377
2018-03-15

Subunit vaccine delivery platform for robust humoral and cellular immune responses

 #551
20180071361
2018-03-15

Non-protein clostridial toxin compositions

 #552
20180071360
2018-03-15

Compositions for the treatment of cancer, and methods for testing and using the same

 #553
20180064805
2018-03-08

Method of Vaccination Comprising a Histone Deacetylase Inhibitor

 #554
20180057571
2018-03-01

Methods of treating and preventing infections and associated conditions

 #555
20180056085
2018-03-01

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #556
20180042990
2018-02-15

METHOD FOR IMPROVING AN INTESTINAL MICROFLORA AND PROMOTING GROWTH OF ANIMALS BY USING COLICIN OR MICROORGANISM CAPABLE OF EXPRESSING THE SAME

 #557
20180042243
2018-02-15

Reagents and methods for inhibiting or disrupting biofilm

 #558
20180037612
2018-02-08

VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS

 #559
20180036368
2018-02-08

COMBINED VACCINATION/RADIOTERAPY FOR CANCER TREATMENT

 #560
20180028832
2018-02-01

SYSTEM AND METHOD FOR OPTOGENETIC THERAPY

 #561
20180028628
2018-02-01

Use of toll-like receptor agonist for treating cancer

 #562
20180028623
2018-02-01

Use of pertussis toxin as a therapeutic agent

 #563
20180028602
2018-02-01

Method of inhibiting microglial cell migration and treating traumatic brain injury

 #564
20180028601
2018-02-01

METHODS AND COMPOSITIONS FOR TREATING CANCER

 #565
20180022788
2018-01-25

Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

 #566
20180015172
2018-01-18

Engineered receptor/ligand system for delivery of therapeutic agents

 #567
20180008668
2018-01-11

Albumin-proaerolysin prodrugs

 #568
20180002661
2018-01-04

Compositions of active WNT protein

 #569
20180000970
2018-01-04

RNA GUIDED ERADICATION OF HERPES SIMPLEX TYPE I AND OTHER RELATED HERPESVIRUSES

 #570
20180000921
2018-01-04

Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease

 #571
20170362281
2017-12-21

MUTANT NQ-RHODOPSIN KR 2

 #572
20170360883
2017-12-21

Composition and method for affecting cytokines and NF-κB

 #573
20170354709
2017-12-14

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 #574
20170348362
2017-12-07

Anthelmintic probiotic compositions and methods

 #575
20170333520
2017-11-23

Compositions and methods for the treatment of disorders involving epithelial cell apoptosis

 #576
20170326202
2017-11-16

Pirin polypeptide and immune modulation

 #577
20170319657
2017-11-09

Method of treating a bladder cancer using a chimeric EGF-targeted bacterial toxin

 #578
20170305966
2017-10-26

Method for producing a stable precipitate enriched in phycobiliproteins

 #579
20170296656
2017-10-19

Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines

 #580
20170290893
2017-10-12

Treatment of infection by human enterovirus D68

 #581
20170275382
2017-09-28

Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof

 #582
20170266278
2017-09-21

Flagellin-based agents and uses including effective vaccination

 #583
20170258905
2017-09-14

Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy

 #584
20170252399
2017-09-07

PHARMACEUTICAL AND FOOD COMPOSITIONS FOR INDUCING SATIATION AND PROLONGING SATIETY IN SUBJECTS IN NEED THEREOF

 #585
20170240602
2017-08-24

Pulmonary administration of pyocins for treating bacterial respiratory infections

 #586
20170239326
2017-08-24

Methods and compositions for the treatment of radiation-related disorders

 #587
20170234871
2017-08-17

proteins

 #588
20170232080
2017-08-17

Treatment of migraine headaches with presynaptic neurotoxin

 #589
20170224768
2017-08-10

LEUKOTOXIN E/D AS A NEW ANTI-INFLAMMATORY AGENT AND MICROBICIDE

 #590
20170224743
2017-08-10

Method for the treatment of acne

 #591
20170216415
2017-08-03

Compositions for the inhibition of

#592
20170216398
2017-08-03

Pseudomonas exotoxin A with less immunogenic B cell epitopes

 #593
20170204145
2017-07-20

Anti-inflammatory properties of a surface protein of propionibacterium freudenreichii

 #594
20170202908
2017-07-20

AGENT FOR PROMOTING SUBSTANCE INCORPORATION IN INTESTINAL TRACT

 #595
20170190758
2017-07-06

Engineered receptor and their use

 #596
20170174729
2017-06-22

Modification of cupredoxin derived peptides

 #597
20170173173
2017-06-22

Skin Permeating and Cell Entering (SPACE) Peptides and Methods of Use Thereof

 #598
20170151307
2017-06-01

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

 #599
20170145097
2017-05-25

Human monoclonal antibodies specific for CD22

 #600
20170145061
2017-05-25

ENGINEERED BACTEROIDES OUTER MEMBRANE VESICLES